chartexchange

Gain Therapeutics Q3 Loss Narrows

RTTNews | Nov 10, 2026 1:48 PM EST


(RTTNews) - Gain Therapeutics, Inc. (GANX) on Tuesday reported a narrower net loss for the third quarter of 2026 compared with the same period in 2025, as reduced research and development and general and administrative expenses lowered overall operating costs.

Read original article